- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2014-03-07 17:19:09
- Reporting Period:
- Filing Date:
- Accepted Time:
- 2014-03-07 17:19:09
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1145197||Insulet Corp||PODD||Surgical & Medical Instruments & Apparatus (3841)||043523891|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1600891||Haas Tracey Wielinski||C/o Insulet Corporation |
9 Oak Park Drive
Bedford MA 01730
|Vp, Global Regulatory, Ca, Qa||No||Yes||No||No|
Reported Non-Derivative Transactions
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
Reported Derivative Transactions
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Employee Stock Option (Right to Buy)||Disposition||2014-03-06||5,000||$0.00||5,000||$23.27|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- Includes 15,000 restricted stock units granted on February 1, 2013, which vest one-third of the total units on February 1, 2015, one-third of the total units on February 1, 2016 and one-third of the total units on February 1, 2017, subject to continued employment; and 9,000 restricted stock units granted on March 3, 2014 which vest one-third of the total units on March 3, 2015, one-third of the total units on March 3, 2016, and one-third of the total units on March 3, 2017. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2013.
- The price reported represents the weighted average sales price of the shares sold. The shares were sold at varying prices in the range of $48.60 to $49.64. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.